Drawing for OIL TO POWDER

USPTO serial 90044403

OIL TO POWDER

Reviewed by CopyMark Law Group

Reg. 7370019Status 700Registered
Filing date
Status date
Registration date
Apr 30, 2024
Examiner
LOOK, JEFFREY J
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with OIL TO POWDER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Shoko Naruo

ONE US BANK PLAZAST. LOUIS, MO 63101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Cannabis extracts for use in the manufacture of foods; cannabis extracts for the manufacture of cosmetics; cannabis extracts for the manufacture of pharmaceutical preparations; proteins for the food industry; proteins for the manufacture of food supplements; herbal extracts, except essential oils, for the manufacture of cosmetics; plant extracts, except essential oils, for manufacture of cosmetics; biological preparations for use in industry and science; antioxidants for the manufacture of cosmetics; antioxidants for the manufacture of food supplements; antioxidants for the manufacture of food and beverages; antioxidants for the manufacture of pharmaceutical preparations; chemical preparations used in industry; chemical preparations used in the manufacture of foods; chemical preserving agents for foodstuffs; chemicals used as food additives in the manufacture of foods; plant extracts for the manufacture of pharmaceutical preparations; plant extracts for the manufacture of cosmetics; extracts made of medicinal plants for use in the manufacture of foods, beverages, dietary supplements, pharmaceuticals; antioxidants for use in the manufacture of foods, beverages, cosmetics, dietary supplements, pharmaceuticals; processed hemp, namely, hemp protein for use in manufacturing foods, beverages, cosmetics, pharmaceuticals; none of the foregoing items containing Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis, and none comprised of cannabidiol (CBD) above a naturally occurring trace amountACTIVE—
003Preparations for body and beauty care for personal use, namely, cosmetic skin and body lotions, creams and gels, cosmetic bath soaps, hair shampoos and conditioners, non-medicated lip balms, facial cosmetics, deodorants for personal use, deodorant soap, cosmetic skin peels, antioxidants sold as a component of cosmetics; perfumery; essential oils; ointments for cosmetic purposes; herbal aromatic essences in the nature of essential oils; essential oils for aroma therapy; oils for cosmetic purposes; essential oils for personal use; essential oils and aromatic extracts comprised of essential oils; essential oils for calming down the nerves; essential essences and oils; herbal extracts for cosmetic purposes; phytocosmetic preparations; hair lotions; bath salts, not for medical use; dentifrices; non-medicated dental and mouth care preparations; cannabis for cosmetic purposes, namely, cannabis based bath soaps, skin lotions and moisturizers, bath lotions, hair shampoos and conditions, skin toners and skin cleansers, cosmetic skin peels, and antioxidants sold as a component of cosmetics; none of the foregoing containing Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis; hemp extracts sold as a component of cosmetics, aroma preparations in the nature of essential oils for the preparation of non-medicated herbal teas, substances used as flavoring agents for food stuffs in the nature of essential oils; aroma preparations in the nature of essential oils use in the preparation of non-medicated infusions for foods and beverages; none of the foregoing containing hemp with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis, and none comprised of cannabidiol (CBD) above a naturally occurring trace amountACTIVE—
005Chemical food supplements; Pharmaceutical preparations for use in the treatment of pain, nausea, insomnia, PTSD, cancer, seizures, anxiety, diabetes, colds and flu, muscle and joint pain, arthritis, antiviral inflammatory diseases, Covid 19; medical preparations for use in the treatment of pain, nausea, insomnia, PTSD, cancer, seizures, anxiety, diabetes, colds and flu, muscle and joint pain, arthritis, skin rashes, Covid 19, inflammatory diseases; veterinary preparations for use in the treatment of pain, nausea, seizures, anxiety, muscle and joint pain, arthritis, skin rashes, antiviral inflammatory diseases, Covid 19; food supplements for human and veterinary use; medicinal products and natural remedies, namely, cough syrup, topical analgesics, medicated skin creams, natural remedies in the nature of herbal tinctures for medicinal use, medications for the treatment of muscles and joint pain, seizures, insomnia, nausea, antiviral inflammatory diseases, Covid 19; extracts made of medicinal plants for pharmaceutical and medicinal use; dietetic preparations specially adapted for medical use; food supplements; antioxidants in the nature of a food supplement; dietetic foodstuffs and preparations for medical or veterinary use; food supplements for humans; food supplements for animals; cannabis for medical purposes, namely, in the nature of medicinal herbs, in the nature of a medicinal herbal extract, topical analgesics, medicated skin and body lotions, creams, gels and balms, cannabis based pills, capsules, tinctures and liquids for use in treating pain, nausea, insomnia, PTSD, cancer, seizures, eating disorders; hemp extracts for pharmaceutical purposes; plasters, namely, medical plasters, surgical plasters, corn plasters, adhesive plasters for medical purposes, gummed taffeta plasters; materials for dressings, namely, medical and surgical dressings, bandages for skin wounds, surgical bandages, antiseptic liquid bandages, bandages impregnated with medicinal cannabis extracts; processed hemp, namely, hemp protein dietary supplements, hemp protein supplement shakes, hemp seed oil dietary supplement preparations; none of the foregoing items containing Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis and none comprised of cannabidiol (CBD) above a naturally occurring trace amountACTIVE—
030Flowers and leaves as tea substitutes; preparations for making tea-based beverages; non medicinal herb teas; Flavorings for food, except essential essences and oils; food flavorings, except essential oils; food stuffs comprised of hemp, namely, chocolates, candy, granola based snack foods, coffee based snack foods, rice based snack foods, snack cakes, cookies, brownies, corn based snack foods, granola snacks, corn based snack foods; cereal preparations, namely, cereal bars, high protein cereal bars, cereal based energy bars, breakfast cereals, cereal based snack foods, processed cereal flakes; processed seeds used as spices; processed hemp in the nature of dried herbs, dried herbs in powdered form; Chemicals for use in foods for culinary purposes, namely, cream of tartar or gluten; none of the foregoing items containing Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) concentration of more than 0.3 percent on a dry weight basis and none comprised of cannabidiol (CBD) above a naturally occurring trace amountACTIVE—
042Quality control of pharmaceuticals, medicinal and cosmetic preparations as well as for food products; Evaluation, testing and analysis of pharmaceutical, medicinal and cosmetic preparations as well as of food products to assure compliance with industry standards; Certification in the nature of testing, evaluation and analysis of the goods of others to determine conformity with certification standards; quality control of raw materials; none of the foregoing services involving the possession or dissemination of goods containing hemp with a delta-9 tetrahydrocannabinol THC concentration of more than 0.3 percent on a dry weight basisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 30, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 30, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 13, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 13, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 24, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 22, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 22, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Dec 22, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 22, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 22, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 22, 2023ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Dec 19, 2023PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Nov 30, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 28, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 28, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 28, 2023ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 6, 2023GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 6, 2023GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 6, 2023CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 27, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 26, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 26, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 30, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 20, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 20, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 19, 2023ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 18, 2023GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jan 18, 2023GNSIINQUIRY TO SUSPENSION E-MAILED—
Jan 18, 2023CNSISUSPENSION INQUIRY WRITTEN—
Dec 20, 2022RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
May 16, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 16, 2022GNSLLETTER OF SUSPENSION E-MAILED—
May 16, 2022CNSLSUSPENSION LETTER WRITTEN—
May 11, 2022XAECEXAMINER'S AMENDMENT ENTERED—
May 11, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 11, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
May 11, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 11, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 11, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 11, 2022ALIEASSIGNED TO LIE—
Jan 7, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 8, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 8, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 8, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 5, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 4, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 4, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 4, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 4, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 30, 2020DOCKASSIGNED TO EXAMINER—
Oct 19, 2020DOCKASSIGNED TO EXAMINER—
Oct 19, 2020DOCKASSIGNED TO EXAMINER—
Aug 6, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 13, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance